蜜蜂病原体中的菌体耐药性的演变
Emma K Spencer1, Yva Eline2, Lauren Saucedo1
1Department of Biological Sciences, University of Idaho, Moscow, ID.
bioRxiv : the preprint server for biology
|July 19, 2024
概括
蜜蜂面临着细菌威胁. 菌体治疗显示出有希望的结果,但可以出现抗药性. 然而,耐药性往往会降低病原体的毒性,并且可以被菌体克服,这表明一种可行的治疗策略.
科学领域:
- 微生物学 微生物学
- 养蜂 养蜂 养蜂 养蜂 养蜂 养蜂 养蜂 养蜂
- 遗传学 遗传学 是一个
背景情况:
- 蜜蜂幼虫容易受到一种细菌病原体Paenibacillus幼虫的攻击.
- 目前针对蜜蜂疾病的抗生素治疗面临局限性,包括监管障碍和抗生素耐药性.
- 菌体治疗是一种新兴的替代方法,用于治疗蜜蜂群中的细菌感染.
研究的目的:
- 为了研究Paenibacillus幼虫对细菌菌体产生抗性的潜力.
- 分析与P. larvae.菌耐药性相关的遗传基础和健康成本.
- 评估菌体对P.幼虫耐药性的影响在蜜蜂幼虫中的毒性.
主要方法:
- 培养P.的细菌被暴露在多种细菌菌体中,以选择耐药菌株.
- 在耐药分离物上进行全基因组测序,以确定突变.
- 用蜜蜂幼虫中的P.虫分离物进行病毒性测试.
主要成果:
- 幼虫在体外快速发展出对菌体的耐药性,但这往往导致了显著的生长缺陷.
- 在与表面受体,一般细胞功能和 lysogeny 相关的基因中发现了赋予耐药性的突变.
- 与野生类型菌株相比,抗菌的P.幼虫分离物在蜜蜂幼虫中表现出较低的毒性.
- 有证据表明,菌体可以进化以克服P.幼虫的抵抗力.
结论:
- 虽然P.幼虫可以发展细菌的耐药性,但这通常与降低的病原性有关.
- 菌体中的二次突变可能会抵消进化的耐药性,支持菌体治疗的潜力.
- 菌体疗法是一个有希望的,对环境更安全的替代方案,用于管理蜜蜂中P.幼虫感染.
相关概念视频
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
01:30Lytic Cycle of Bacteriophages
70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K
00:43Lysogenic Cycle of Bacteriophages
62.1K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.1K
02:53CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
00:57Antibiotic Selection
52.9K
Overview
52.9K
00:36Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K